| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 12 | |
| #2 | EPO (European Patent Office) | 7 | |
| #3 | Australia | 5 | |
| #4 | Poland | 4 | |
| #5 | Canada | 2 | |
| #6 | Norway | 2 | |
| #7 | China | 1 | |
| #8 | Hungary | 1 | |
| #9 | Russian Federation | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Dasseux Jean-Louis | 35 |
| #2 | Sekul Renate | 24 |
| #3 | Cornut Isabelle | 23 |
| #4 | Buttner Klaus | 18 |
| #5 | Metz Gunther | 17 |
| #6 | Dufourcq Jean | 11 |
| #7 | Buettner Klaus | 6 |
| #8 | Metz Guenther | 6 |
| #9 | Oniciu Daniela Carmen | 1 |
| #10 | Ackermann Rose | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2006217312A1 | Charged lipoprotein complexes and their uses | |
| AU2002300463B2 | Apolipoprotein A-I Agonists And Their Use To Treat Dyslipidemic Disorders | |
| RU2215747C2 | Agonists of apolipoprotein a-i and their using for treatment of dyslipidemia-mediated diseases | |
| HU0003924A2 | Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |